Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2020.455 | A multicenter, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of finerenone on morbidity and mortality in participants with heart failure (NYHA II-IV) and left ventricular ejection fraction ≥ 40% (LVEF ≥ 40%) |
Prof. LEE Pui Wai 李沛威 |
| 2010.356 | A Multicenter, Randomized, Double-Blind, Phase 3 Study of Ramucirumab (IMC-1121B) Drug Product and Best Supportive Care (BSC) Versus Placebo and BSC as Second-Line Treatment in Patients With Hepatocellular Carcinoma Following First-Line Therapy With Sorafenib | Dr. Chan Lam Stephen |
| 2010.030 | A multicenter, randomized, double-blind, placebo controlled phase III study of panobinostat in combination with bortezomib and dexamethasone in patients with relapsed multiple myeloma | Dr. WONG Raymond Siu Ming |
| 2006.057 | A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate the Efficacy and Safety of Saxagliptin in Combination with Glyburide in Subjects with Type 2 Diabetes Who Have Inadequate Glycemic Control on Glyburide Alone | Prof. Tong C.Y. Peter |
| 2007.130 | A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Demonstrate the Lipid-Altering Efficacy and Safety and Tolerability of MK-0524A in Patients with Primary Hypercholesterolemia or Mixed Hyperlipidemia | Dr. So Wing Yee |
| 2010.270 | A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Cardiovascular Outcomes Following Treatment with Alogliptin in Addition to Standard of Care in Subjects with Type 2 Diabetes and Acute Coronary Syndrome | Dr Chow Chun Chung, Francis |
| 2010.385 | A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Cardiovascular Outcomes Following Treatment with Alogliptin in Addition to Standard of Care in Subjects with Type 2 Diabetes and Acute Coronary Syndrome | Dr Yan Ping Yen Bryan |
| 2012.007 | A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of BIIB023 in Subjects With Lupus Nephritis | Prof. TAM Lai Shan |
| 2008.216 | A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of SCH 530348 in Addition to Standard of Care in Subjects with a History of Atherosclerotic Disease: Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2 | Prof. Yu Cheuk Man |
| 2005.151 | A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of the Addition of MK-0431 to Patients with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Glimepiride Alone or in Combination with Metformin | Dr. So Wing Yee |
| 2013.605 | A Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-escalation Study to Determine the Depth and Duration of Hepatitis B Surface Antigen (HBsAg) Reduction After a Single Intravenous Dose of ARC-520 in Combination with Entecavir in Patients with Chronic Hepatitis B Virus (HBV) Infection, followed by a two-dose open label cohort and an open label single dose cohort in treatment naïve patients | Prof. CHAN Henry Lik Yuen |
| 2015.189 | A Multicenter, Randomized, Double-blind, Placebo-controlled, Multi-dose Study to Determine the Depth of Hepatitis B Surface Antigen (HBsAg) Reduction Following Intravenous ARC-520 in Combination with Entecavir or Tenofovir in Patients with HBeAg Negative, Chronic Hepatitis B Virus (HBV) Infection |
Prof. CHAN Henry Lik Yuen 陳力元教授 |
| 2015.190 | A Multicenter, Randomized, Double-blind, Placebo-controlled, Multi-dose Study to Determine the Depth of Hepatitis B Surface Antigen (HBsAg) Reduction Following Intravenous ARC-520 in Combination with Entecavir or Tenofovir in Patients with HBeAg Positive, Chronic Hepatitis B Virus (HBV) Infection |
Prof. CHAN Henry Lik Yuen 陳力元教授 |
| 2008.207 | A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group-Comparison Trial of Aripiprazole in the Treatment of Patients with Bipolar Disorder Experiencing a Manic Episode or Mixed Episode | Prof. Wing Yun Kwok |
| 2005.093 | A Multicenter, Randomized, Double-Blind, Placebo-controlled, Parallel Group, Phase II Study to Evaluate the Safety and Efficacy of Oral Dosing with GW679769 (50mg or 150mg) for Three Consecutive Days When Administered with a Single Intravenous Dose of Ondansetron Hydrochloride for the Prevention of Post-operative Nausea and Vomiting and Post-discharge Nausea and Vomiting in Female Subjects with Known Risk Factors for Post-operative Nausea and Vomiting Who are Undergoing Laparoscopic/Laparotomic Surgical Procedures Associated with an Increased Emetogenic Risk | Prof. Gin Tony |
| 2021.187 | A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Dapirolizumab pegol in Study Participants with Moderately to Severely Active Systemic Lupus Erythematosus |
Prof. TAM Lai Shan 譚麗珊 教授 |
| 2012.332 | A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate Cardiovascular Outcomes of TAK-875, 50 mg in Addition to Standard of Care in Subjects with Type 2 Diabetes and with Cardiovascular Disease or Multiple Risk Factors for Cardiovascular Events | Prof. YU Cheuk Man |
| 2012.278 | A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate Cardiovascular Outcomes of TAK-875, 50 mg in Addition to Standard of Care in Subjects with Type 2 Diabetes and with Cardiovascular Disease or Multiple Risk Factors for Cardiovascular Events | Dr. TSANG Chiu Chi |
| 2012.274 | A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate Cardiovascular Outcomes of TAK-875, 50 mg in Addition to Standard of Care in Subjects with Type 2 Diabetes and with Cardiovascular Disease or Multiple Risk Factors for Cardiovascular Events | Dr. CHOW Francis Chun-Chung |
| 2013.154 | A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE III STUDY TO ASSESS THE EFFICACY, SAFETY AND TOLERABILITY OF ALEGLITAZAR MONOTHERAPY COMPARED WITH PLACEBO IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2D) WHO ARE DRUG-NA_VE TO ANTIHYPERGLYCEMIC THERAPY | Dr. Tsang Chiu Chi |
| 2013.153 | A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE III STUDY TO ASSESS THE EFFICACY, SAFETY AND TOLERABILITY OF ALEGLITAZAR MONOTHERAPY COMPARED WITH PLACEBO IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2D) WHO ARE DRUG-NA_VE TO ANTIHYPERGLYCEMIC THERAPY | Prof. Kong Pik Shan |
| 2009.218 | A Multicenter, Randomized, Doubled-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of SCH 530348 in Addition to Standard of Care in Subjects with Acute Coronary Syndrome: Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA-CER) | Professor Cheuk-Man YU |
| 2006.157 | A Multicenter, Randomized, Open Label Dose Finding Study of RO0503821 in Anemic Patients with Stage IIIB or IV Non-Small Cell Lung Cancer Receiving First Line Myelosuppressive Chemotherapy | Prof. Mok Tony |
| 2006.275 | A Multicenter, Randomized, Open-Label Comparison of the Safety and Efficacy of Tigecycline with That of Ampicillin-Sulbactam or Amoxicillin-Clavulanate to Treat Complicated Skin and Skin Structure Infections | Prof. Andrew Burd |
| 2013.237 | A Multicenter, Randomized, Open-Label, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib (E7080) Versus Sorafenib in First-Line Treatment of Subjects With Unresectable Hepatocellular Carcinoma | Dr. CHAN Stephen L. |
| 2014.090 | A Multicenter, Single-Arm, Open-Label, Post-Marketing Safety Study to Evaluate the Risk of Seizure Among Subjects with Metastatic Castration-Resistant Prostate Cancer (mCRPC)Treated with Enzalutamide Who Are at Potential Increased Risk of Seizure | Prof. NG Chi Fai |
| 2009.196 | A Multicentered, Controlled, Randomized Study to Evaluate and Compare the Rate of Parastomal Herniation After Permanent Stoma Formation With and Without Reinforcement With an Intraperitoneal Onlay Mesh (IPOM) | Doctor POON CHI MING |
| 2023.247 | A multicentered, single-group Phase 2, exploratory, open-label study to investigate safety and effect of sparsentan in combination with sodium glucose cotransporter-2 (SGLT2) inhibition in the treatment of adult participants with Immunoglobulin A nephropathy (IgAN) |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2002.436 | A Multicentre Phase III Study of Interferon-beta-1a for the Treatment of Chronic Hepatitis C in Asian Patients | Prof. Sung Jao Yiu Joseph |
| 2016.223 | A multicentre randomised double-blind, placebo-controlled trial of Chinese medicine and/or progesterone in women with threatened miscarriage - a trial centre in Hong Kong |
Dr. WANG Chi Chiu 黄志超 |
| 2014.441 | A MULTICENTRE RANDOMIZED PROGRAM BY USING A DIABETIC KIDNEY DISEASE (DKD) REGISTRY TO TREAT TO MULTIPLE TARGETS (TMT) (DKD-TMT) | Dr. LUK Andrea |
| 2013.609 | A MULTICENTRE RANDOMIZED PROGRAM BY USING A DIABETIC KIDNEY DISEASE (DKD) REGISTRY TO TREAT TO MULTIPLE TARGETS (TMT) (DKD-TMT) | Prof. CHAN Juliana |
| 2014.443 | A MULTICENTRE RANDOMIZED PROGRAM BY USING A DIABETIC KIDNEY DISEASE (DKD) REGISTRY TO TREAT TO MULTIPLE TARGETS (TMT) (DKD-TMT) | Dr. TSANG Chiu Chi |
| 2012.199 | A Multicentre Randomized Program to Compare the Effect of the Joint Asia Diabetes Evaluation (JADE, structured care) versus the DIAbetes MONitoring Database (DIAMOND, usual care) Programs in Type 2 Diabetic Patients in Asia Pacific Region | Prof. CHAN Juliana |
| 2023.412 | A multicentre retrospective observational study to evaluate the association between the time lag of lens extraction after acute primary angle closure (APAC) and treatment outcomes | Dr. CHAN Poemen Pui Man |
| 2020.138 | A MULTICENTRE RETROSPECTIVE STUDY -- CLINICAL OUTCOMES OF CONSERVATIVE AND SURGICAL TREATMENTS IN UROGENITAL PROLAPSE AND URINARY INCONTINENCE | Dr. CHEUNG Rachel Yau Kar |
| 2021.478 | A multicentre retrospective study on the clinical and radiological features, and outcome of surgical treatment in Atypical Femoral Fractures in Hong Kong |
Prof. WONG Ronald Man Yeung 黃文揚 |
| 2013.223 | A MULTICENTRE STUDY FOR THE EVALUATION OF EFFICACY AND SAFETY OF BUPRENORPHINE TRANSDERMAL PATCH (NORSPANｮ OR SOVENORｮ TRANSDERMAL PATCH)IN PATIENTS WITH NON-MALIGNANT PAIN OF MODERATE TO SEVERE INTENSITY DUE TO OSTEOARTHRITIS, RHEUMATOID ARTHRITIS, LOWER BACK PAIN AND JOINT / MUSCLE PAIN, WHEN AN OPIOID IS NECESSARY FOR OBTAINING ADEQUATE ANALGESIA | Dr. CHAN Simon KC |
| 2010.192 | A multicentre study on the precalence of gestational diabetes mellitus among women referred for prenatal diagnosis with suspected fetal structural and chromosomal anomalies, and the relationship between the degree of glucose intolerance with the type and | Prof. Lao Terence |
| 2009.575 | A multicentre study on the seasonal variation of fetal non-syndromal structural anomalies and the association with environmental factors in Hong Kong | Prof. Lao Terence |
| 2010.281 | A Multicentre Study To Investigate The Prevalence And Factors Associated With Depression In Chinese Patients With Type 2 Diabetes | Professor Chan Juliana |
| 2010.511 | A multicentre, international, randomised, parallel group, double blind study to evaluate Cardiovascular safety of linagliptin versus glimepiride in patients with type 2 diabetes mellitus at high cardiovascular risk. The CAROLINA Trial. | Dr. CHOW Francis Chun Chung |
| 2010.510 | A multicentre, international, randomised, parallel group, double blind study to evaluate Cardiovascular safety of linagliptin versus glimepiride in patients with type 2 diabetes mellitus at high cardiovascular risk. The CAROLINA Trial. | Dr. TSANG Chiu Chi |
| 2012.368 | A multicentre, open-label, long-term, safety, tolerability, and efficacy study of retigabine immediate-release (IR) in Asian adults with partial onset seizures (extension of study RTG114855) | Dr Kwan Patrick Kwok Leung |
| 2009.189 | A Multicentre, Open-label, Prospective Long-term Study Evaluation the Clinical Benefit and Effectiveness of Quetiapine Fumarate Extended-Release Tablets in Subjects with Schizophrenia | Prof Lee Edwin Ho Ming |
| 2021.123 | A multicentre, open, long-term clinical investigation evaluating safety, performance and patient reported outcomes with an active osseointegrated steady-state implant system in adult subjects with conductive hearing loss, mixed hearing loss or single-sided sensorineural deafness. |
Prof. TONG Michael C.F. 唐志輝 |
| 2024.450 | A Multicentre, Prospective, Randomized, Open Label, Blinded-endpoint Trial to Optimize the Use of Intravenous Tenecteplase in Participants with Acute Ischemic Stroke | Prof. LEUNG Thomas Wai Hong |
| 2007.128 | A Multicentre, Randomised Study to Examine the Effects of Telephone Intervention in Patients with Coronary Heart Disease and Diabetes | Dr. So Wing Yee |
| 2021.401 | A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase III Study Evaluating the Efficacy and Safety of Anifrolumab in Asian Participants with Active Systemic Lupus Erythematosus |
Dr. TAM Lai Shan 譚麗珊 |
| 2004.226 | A Multicentre, Randomized Study to Examine the Effects of Disease Management on Development of End Stage Renal Disease in Type 2 Diabetic Patients with Nephropathy | Prof. Chan Chung Ngor Juliana |
Page 13 of 262.